THE PRIMARY ENDPOINT OF BIO-RISE CHINA WAS PRESENTED AT TCT 2021 LATE BREAKING TRIALS This first-in-human study assessed the safety and efficacy of a Biolimus A9™ coated balloon and showed excellent results in small vessels with 0.16 mm late loss at 9 months.
CE MARK APPROVAL FOR BIOLIMUS A9™ COATED COBALT CHROMIUM CORONARY STENT SYSTEM BIOFREEDOM™ ULTRA BioFreedom™ Ultra is Biosensors International new, novel thin strut CoCr polymer and carrier-free Drug Coated Stent with Biosensors proprietary limus BA9™, a highly lipophilic anti-restenotic drug, developed specifically for use in coronary vascular applications. BioFreedom™ Ultra successfully extends the LEADERS FREE legacy in LEADERS FREE III.